Skip to main content

Rocket One Inc.

RKTO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001711786

No open-market purchases or sales by Rocket One Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.62M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Rocket One Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of RKTO: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders1715−2
Shares990.4K1.05M+57.6K (+5.8%)
Value$1.58M$1.25M−$337.9K (−21.3%)

New holders (3)

Institutions that held Rocket One Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to RKTO in Q3 2021
InstitutionSharesValue% of portfolio
Northern Trust Corp58,443$69.0K0.00%
Bank of New York Mellon Corp38,890$46.0K0.00%
UBS Group AG972$1.00K0.00%

Sold out (5)

Institutions that held Rocket One Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of RKTO in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Citadel Advisors LLC46,396$74.0K
Goldman Sachs Group Inc37,460$60.0K
JPMorgan Chase & Co57$0
Bank of America Corp7$0
Royal Bank of Canada58$0